Literature DB >> 1501881

Biochemical properties of the growth suppressor/oncoprotein p53.

M Montenarh1.   

Abstract

The cellular p53 protein is so called because of its molecular weight as determined by SDS-polyacrylamide gel electrophoresis. It was originally classified as a nuclear oncogene product when it was shown by DNA transfection experiments that p53 is able to extend the lifespan of primary rodent cell cultures and to cooperate with an activated ras oncogene to achieve complete transformation of primary cells. However, there is now conclusive evidence that loss of normal p53 expression may be an important step in cell transformation and tumorigenesis. Furthermore, it has been shown that mutant p53 was used for the experiments demonstrating the immortalizing and transforming capacity of p53. Wild-type p53 seems to negatively regulate cell growth and division. So far, the basic function of p53 is not known. Biochemical variability seems to be a key feature of p53 and an understanding of biochemical variations in the p53 protein may contribute to an understanding of how p53 is regulated or how p53 may regulate cell proliferation. Thus, the present review will focus on the biochemical properties of p53.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1501881

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Immunohistochemical studies of sensory neurons in rat olfactory epithelium.

Authors:  C C Huang; K Chen; T Y Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

Review 2.  [Stress proteins: their growing significance in medicine].

Authors:  F Fracella; L Rensing
Journal:  Naturwissenschaften       Date:  1995-07

3.  An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.

Authors:  Q J Zhang; R Gavioli; G Klein; M G Masucci
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 4.  Tumor suppressor genes in molecular medicine.

Authors:  F Hoppe-Seyler; K Butz
Journal:  Clin Investig       Date:  1994-08

5.  Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma.

Authors:  Y Soini; K Nuorva; D Kamel; R Pöllänen; K Vähäkangas; V P Lehto; P Pääkkö
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

6.  Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines.

Authors:  M O Grimm; B Jürgens; W A Schulz; K Decken; D Makri; B J Schmitz-Dräger
Journal:  Urol Res       Date:  1995

7.  Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.

Authors:  F Hoppe-Seyler; K Butz
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Analysis of a protein-binding domain of p53.

Authors:  J M Ruppert; B Stillman
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Significance of P53 in human thyroid tumors.

Authors:  D Simon; P E Goretzki; V Gorelev; B Ebling; E Reishaus; J Lyons; H Haubruck; H D Röher
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

10.  Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblasts.

Authors:  J F Cavender; A Conn; M Epler; H Lacko; M J Tevethia
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.